Immix Biopharma (IMMX) Insider Trading & Ownership $1.79 +0.11 (+6.55%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immix Biopharma (NASDAQ:IMMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.90%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$341,415.00Number OfInsiders Selling(Last 12 Months)0 Get IMMX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMMX Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Immix Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2024Carey NgDirectorBuy10,000$1.86$18,600.00 7/24/2024Jason HsuDirectorBuy6,000$2.15$12,900.00 7/18/2024Jason HsuDirectorBuy3,200$2.07$6,624.00 6/7/2024Gabriel S MorrisCFOBuy2,500$2.12$5,300.00 6/7/2024Ilya M RachmanCEOBuy2,600$2.13$5,538.00 6/4/2024Gabriel S MorrisCFOBuy3,300$1.81$5,973.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/14/2024Gabriel S MorrisCFOBuy4,500$2.23$10,035.00 5/14/2024Ilya M RachmanCEOBuy4,300$2.25$9,675.00 12/11/2023Jason HsuDirectorBuy31,000$4.67$144,770.00 12/8/2023Jason HsuDirectorBuy25,000$4.88$122,000.00 (Data available from 1/1/2013 forward) IMMX Insider Trading Activity - Frequently Asked Questions Who is on Immix Biopharma's Insider Roster? The list of insiders at Immix Biopharma includes Carey Ng, Gabriel S Morris, Helen C Adams, Ilya M Rachman, Jason Hsu, Magda Marquet, Melissa Jane Buchan, and Sean Senn. Learn more on insiders at IMMX. What percentage of Immix Biopharma stock is owned by insiders? 48.90% of Immix Biopharma stock is owned by insiders. Learn more on IMMX's insider holdings. Which Immix Biopharma insiders have been buying company stock? The following insiders have purchased IMMX shares in the last 24 months: Carey Ng ($44,400.00), Gabriel S Morris ($21,308.00), Helen C Adams ($38,480.00), Ilya M Rachman ($15,213.00), Jason Hsu ($286,294.00), Magda Marquet ($26,710.00), and Melissa Jane Buchan ($49,200.00). How much insider buying is happening at Immix Biopharma? Insiders have purchased a total of 146,400 IMMX shares in the last 24 months for a total of $481,605.00 bought. Immix Biopharma Key ExecutivesDr. Ilya Rachman M.B.A. (Age 51)M.D., MBA, Ph.D., Co-Founder, CEO & Chairman Compensation: $637.5kMr. Gabriel Morris B.A. (Age 37)CFO & Director Compensation: $637.5kMr. Sean Senn J.D.M.B.A., M.Sc., MBA, MSc, Co-FounderDr. Vladimir P. Torchilin D.Sc. (Age 77)MSE, Ph.D., Scientific Co-Founder Mr. Ben H. Lyon J.D.Executive VP & General CounselDr. Graham Ross FFPM (Age 64)M.D., Chief Medical Officer & Head of Clinical Development Mr. Nandan Oza B.S. (Age 62)Head of Chemistry, Manufacturing & Control Dr. David MarksChief Medical Officer of Cell TherapyMr. Gerhard BauerHead of Cell Thearpy Manufacturing More Insider Trading Tools from MarketBeat Related Companies RAPT Therapeutics Insider Buying BioAtla Insider Buying Landos Biopharma Insider Buying Seres Therapeutics Insider Buying Caribou Biosciences Insider Buying DiaMedica Therapeutics Insider Buying Actuate Therapeutics Insider Buying scPharmaceuticals Insider Buying Inozyme Pharma Insider Buying Kyverna Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:IMMX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
